Search by Drug Name or NDC
NDC 00006-0335-30 BELSOMRA 20 mg/1 Details
BELSOMRA 20 mg/1
BELSOMRA is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Merck Sharp & Dohme LLC. The primary component is SUVOREXANT.
MedlinePlus Drug Summary
Suvorexant is used treat insomnia (difficulty falling asleep or staying asleep). Suvorexant is in a class of medications called orexin receptor antagonists. It works by blocking the action of a certain natural substance in the brain that causes wakefulness.
Related Packages: 00006-0335-30Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Suvorexant
Product Information
| NDC | 00006-0335 |
|---|---|
| Product ID | 0006-0335_18f09198-23e9-48c9-8426-e39828d75ad8 |
| Associated GPIs | 60500070000320 |
| GCN Sequence Number | 072693 |
| GCN Sequence Number Description | suvorexant TABLET 20 MG ORAL |
| HIC3 | H2E |
| HIC3 Description | SEDATIVE-HYPNOTICS,NON-BARBITURATE |
| GCN | 36971 |
| HICL Sequence Number | 041333 |
| HICL Sequence Number Description | SUVOREXANT |
| Brand/Generic | Brand |
| Proprietary Name | BELSOMRA |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | suvorexant |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 20 |
| Active Ingredient Units | mg/1 |
| Substance Name | SUVOREXANT |
| Labeler Name | Merck Sharp & Dohme LLC |
| Pharmaceutical Class | Cytochrome P450 3A Inhibitors [MoA], Orexin Receptor Antagonist [EPC], Orexin Receptor Antagonists [MoA], P-Glycoprotein Inhibitors [MoA] |
| DEA Schedule | CIV |
| Marketing Category | NDA |
| Application Number | NDA204569 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00006-0335-30 (00006033530)
| NDC Package Code | 0006-0335-30 |
|---|---|
| Billing NDC | 00006033530 |
| Package | 3 CASE in 1 CARTON (0006-0335-30) / 1 BLISTER PACK in 1 CASE (0006-0335-10) / 10 TABLET, FILM COATED in 1 BLISTER PACK |
| Marketing Start Date | 2014-08-29 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 14.1569 |
| Pricing Unit | EA |
| Effective Date | 2024-01-06 |
| NDC Description | BELSOMRA 20 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis